Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | BMY | VRTX | REGN | ||
Company | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Regeneron Pharmaceuticals | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NASDAQ | ||
Open | 53.00 | 420.30 | 971.04 | ||
High | 53.69 | 420.42 | 976.75 | ||
Low | 52.85 | 412.65 | 962.41 | ||
Last | 53.25 | 417.32 | 966.30 | ||
Change | +0.70 | -1.14 | +2.75 | ||
% Change | +1.33% | -0.27% | +0.29% | ||
Volume | 13,077,600 | 905,400 | 314,700 | ||
20-Day Average Volume | 20,769,045 | 1,045,085 | 442,695 | ||
Previous Close | 52.55 | 418.46 | 963.55 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 52.40 | 415.37 | 967.01 | ||
20-Day Raw Stochastic | 62.50% | 38.30% | 44.10% | ||
20-Day Relative Strength | 59.38% | 50.28% | 54.40% | ||
Weighted Alpha | -19.90 | +30.80 | +23.30 | ||
Today's Opinion | 8% Buy | 56% Buy | 80% Buy | ||
Previous Opinion | 8% Sell | 56% Buy | 80% Buy | ||
Last Month's Opinion | 56% Sell | 100% Buy | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +2.64% since 03/20/24 | +1.26% since 03/20/24 | -0.07% since 03/20/24 | ||
Low | 51.52 on 03/22/24 | 412.19 on 03/22/24 | 952.47 on 03/25/24 | ||
High | 53.69 on 03/27/24 | 420.42 on 03/27/24 | 979.26 on 03/21/24 | ||
1-Month | |||||
%Chg | +5.42% since 02/27/24 | -3.16% since 02/27/24 | -2.72% since 02/27/24 | ||
Low | 50.28 on 02/29/24 | 406.97 on 03/15/24 | 947.37 on 03/20/24 | ||
High | 55.03 on 03/13/24 | 433.99 on 03/04/24 | 998.33 on 02/28/24 | ||
3-Month | |||||
%Chg | +3.98% since 12/27/23 | +2.27% since 12/27/23 | +10.51% since 12/27/23 | ||
Low | 47.58 on 02/06/24 | 403.43 on 01/02/24 | 871.39 on 01/02/24 | ||
High | 55.03 on 03/13/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | ||
6-Month | |||||
%Chg | -8.02% since 09/27/23 | +19.35% since 09/27/23 | +16.06% since 09/27/23 | ||
Low | 47.58 on 02/06/24 | 341.85 on 10/03/23 | 769.19 on 10/27/23 | ||
High | 58.46 on 09/29/23 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 106,506,192 | 108,091,568 | 105,761,168 | ||
Shares Outstanding, K | 2,026,759 | 258,308 | 109,762 | ||
Annual Sales | 45,006,000,000 | 9,869,200,000 | 13,117,200,000 | ||
Annual Net Income | 8,025,000,000 | 3,619,600,000 | 3,953,600,000 | ||
Last Quarter Sales | 11,477,000,000 | 2,517,700,000 | 3,434,300,000 | ||
Last Quarter Net Income | 1,762,000,000 | 968,800,000 | 1,159,600,000 | ||
60-Month Beta | 0.38 | 0.35 | 0.11 | ||
Per-Share Information | |||||
Most Recent Earnings | 1.70 on 02/02/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | ||
Latest Earnings Date | 04/25/24 | 05/06/24 | 05/02/24 | ||
Most Recent Dividend | 0.600 on 01/04/24 | N/A | N/A | ||
Next Ex-Dividends Date | 04/04/24 | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 6.97 | 30.95 | 25.57 |